Kopeć-Mędrek Magdalena, Widuchowska Małgorzata, Kucharz Eugeniusz J
Department of Internal Medicine and Rheumatology, Katowice, Poland.
Reumatologia. 2016;54(6):306-309. doi: 10.5114/reum.2016.64907. Epub 2016 Dec 30.
Calprotectin also known as MRP8/14 or S100A8/A9 is a heterodimeric complex of two S100 calcium-binding proteins: myeloid-related protein 8 (MRP-8 or S100A8) and MRP-14 (or S100A9). At present, according to many authors, it is considered that calprotectin MRP8/14 is a potentially more sensitive biomarker of disease activity in rheumatoid disease than conventional inflammatory indices such as the erythrocyte sedimentation rate, C-reactive protein and others. A review of the literature on concentration of calprotectin in patients with some rheumatic diseases (rheumatoid arthritis, juvenile idiopathic arthritis, adult-onset Still's disease, systemic vasculitis, polymyalgia rheumatica, ankylosis spondylitis, systemic lupus erythematosus, and primary Sjögren's syndrome) is presented.
钙卫蛋白也被称为MRP8/14或S100A8/A9,是由两种S100钙结合蛋白组成的异二聚体复合物:髓样相关蛋白8(MRP - 8或S100A8)和MRP - 14(或S100A9)。目前,许多作者认为,与红细胞沉降率、C反应蛋白等传统炎症指标相比,钙卫蛋白MRP8/14可能是类风湿病疾病活动更敏感的生物标志物。本文对一些风湿性疾病(类风湿关节炎、幼年特发性关节炎、成人斯蒂尔病、系统性血管炎、风湿性多肌痛、强直性脊柱炎、系统性红斑狼疮和原发性干燥综合征)患者的钙卫蛋白浓度文献进行了综述。